The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tuberculosis is responsible for one in four of all avoidable adult deaths in developing countries. Increased frequency and accelerated fatality of the disease among individuals infected with human immunodeficiency virus has raised worldwide concern that control programmes may be inadequate, and the emergence of multidrug-resistant strains of Mycobacterium tuberculosis has resulted in several recent fatal outbreaks in the United States. Isonicotinic acid hydrazide (isoniazid, INH) forms the core of antituberculosis regimens; however, clinical isolates that are resistant to INH show reduced catalase activity and a relative lack of virulence in guinea-pigs. Here we use mycobacterial genetics to study the molecular basis of INH resistance. A single M. tuberculosis gene, katG, encoding both catalase and peroxidase, restored sensitivity to INH in a resistant mutant of Mycobacterium smegmatis, and conferred INH susceptibility in some strains of Escherichia coli. Deletion of katG from the chromosome was associated with INH resistance in two patient isolates of M. tuberculosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An INH-resistant strain of mc2155 was shown to become sensitive upon expression of the M. tuberculosis catalase-peroxidase gene, katG, suggesting that susceptibility to INH requires the expression of katG (127).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [127]
Citations
Cites
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Snider, D. E., & Roper, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261011 · Cited by 382
Lysogeny and transformation in mycobacteria: stable expression of foreign genes.
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R., & Jacobs, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6987 · Cited by 326
The Biology of the Mycobacteria
Ratledge, C., & Stanford, J. L. (1982) · Cited by 254
Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis
Zhang, Y., Lathigra, R., Garbe, T., Catty, D., & Young, D. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02120.x · Cited by 182
Self-citationWayne, L. G., & Diaz, G. A. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90200-9 · Cited by 173
Perriëns, J. H., Colebunders, R. L., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y., Pauwels, P., Ryder, R. W., Prignot, J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 162
JACKETT, P. S., ABER, V. R., & LOWRIE, D. B. (1978) · Journal of General Microbiology · doi:10.1099/00221287-104-1-37 · Cited by 162
Nucleotide sequence of katG, encoding catalase HPI of Escherichia coli
Triggs‐Raine, B. L., Doble, B. W., Mulvey, M. R., Sorby, P. A., & Loewen, P. C. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.4415-4419.1988 · Cited by 139
Mulvey, M. R., Sorby, P. A., Triggs‐Raine, B. L., & Loewen, P. C. (1988) · Gene · doi:10.1016/0378-1119(88)90498-2 · Cited by 121
Research works printed but not linked: 4
- Murray, C. J. L., Styblo, K. & Rouillon, A. Bull. Int. Union against Tuberculosis and Lung Disorders 65, 6–24 (1990).
- Cohn, M. L., Kovitz, C., Oda, U. & Middlebrook, G. Am. Rev. Tuberc. 70, 641–664 (1954).
- Youatt, J. Am. Rev. respir. Dis. 99, 729–749 (1969).
- Heym, B. & Cole, S. T. Res. Microbiol. (in the press).
Cited by
Items 101–200 of 1,000
Molecular Biology of Drug Resistance in Mycobacterium tuberculosis
Smith, T., Wolff, K. A., & Nguyen, L. (2012) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2012_279 · Cited by 190
Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen
Maitra, A., Munshi, T., Healy, J., Martin, L. T., Vollmer, W., Keep, N. H., & Bhakta, S. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz016 · Cited by 190
The mycobacterial cell wall: structure, biosynthesis and sites of drug action
Chatterjee, D. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80055-5 · Cited by 189
Li, Z., Kelley, C., Collins, F., Rouse, D., & Morris, S. (1998) · Journal of Infectious Diseases · doi:10.1086/515254 · Cited by 195
Synthetic EthR inhibitors boost antituberculous activity of ethionamide
Willand, N., Dirié, B., Carette, X., Bifani, P., Singhal, A., Desroses, M., Leroux, F., Willery, E., Mathys, V., Déprez-Poulain, R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1950 · Cited by 177
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13
Aggarwal, A., Parai, M. K., Shetty, N., Wallis, D., Woolhiser, L., Hastings, C., Dutta, N. K., Galaviz, S., Dhakal, R. C., Shrestha, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.025 · Cited by 183
Wang, H., Chao, Y., Liu, J., Zhu, W., Wang, G., Xu, L., & Liu, Z. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.011 · Cited by 187
Chen, Q., Chen, J., Liang, C., Feng, L., Dong, Z., Song, X., Song, G., & Liu, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.006 · Cited by 188
Mechanisms of drug resistance in mycobacterium tuberculosis
Wade, M. M. (2004) · Frontiers in Bioscience · doi:10.2741/1289 · Cited by 184
Wolucka, B. A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06395.x · Cited by 182
Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis
Vilchèze, C., Hartman, T., Weinrick, B., Jain, P., Weisbrod, T. R., Leung, L. W., Freundlich, J. S., & Jacobs, W. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704376114 · Cited by 185
Buchmeier, N. A., Newton, G. L., Koledin, T., & Fahey, R. C. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03416.x · Cited by 180
Sepkowitz, K. A., Raffalli, J., Riley, L., Kiehn, T. E., & Armstrong, D. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.2.180 · Cited by 181
Microevolution of extensively drug-resistant tuberculosis in Russia
Casali, N., Nikolayevskyy, V., Balabanova, Y., Ignatyeva, O., Kontsevaya, I., Harris, S. R., Bentley, S. D., Parkhill, J., Nejentsev, S., Hoffner, S. E., et al. (2012) · Genome Research · doi:10.1101/gr.128678.111 · Cited by 181
Luckner, S. R., Liu, N., am Ende, C. W., Tonge, P. J., & Kisker, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.090373 · Cited by 174
Thiol-based redox switches in prokaryotes
Hillion, M., & Antelmann, H. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0102 · Cited by 173
Hameed, H. M. A., Islam, M. M., Chhotaray, C., Wang, C., Liu, Y., Tan, Y., Li, X., Tan, S., Delorme, V., Yew, W. W., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00114 · Cited by 175
Tuberculosis: The drug development pipeline at a glance
Villemagne, B., Crauste, C., Flipo, M., Baulard, A. R., Déprez, B., & Willand, N. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.033 · Cited by 172
Chen, E. S., Wahlström, J., Song, Z., Willett, M. H., Wikén, M., Yung, R. C., West, E. E., McDyer, J. F., Zhang, Y., Eklund, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8784 · Cited by 177
Self-citationZhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Self-citationSuzuki, Y., Katsukawa, C., Tamaru, A., Abe, C., Makino, M., Mizuguchi, Y., & Taniguchi, H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1220-1225.1998 · Cited by 177
Engohang‐Ndong, J., Baillat, D., Aumercier, M., Bellefontaine, F., Besra, G. S., Locht, C., & Baulard, A. R. (2004) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03809.x · Cited by 169
Cheng, S.-J., Thibert, L., Sanchez, T., Heifets, L., & Zhang, Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.528-532.2000 · Cited by 175
Self-citationPotential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis
Anishetty, S., Pulimi, M., & Pennathur, G. (2005) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2005.07.001 · Cited by 177
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis
Vilchèze, C., & Jacobs, W. R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.016 · Cited by 160
Converting Cancer Therapies into Cures: Lessons from Infectious Diseases
Glickman, M. S., & Sawyers, C. L. (2012) · Cell · doi:10.1016/j.cell.2012.02.015 · Cited by 168
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
Vilchèze, C., Av‐Gay, Y., Attarian, R., Liu, Z., Hazbón, M. H., Colangeli, R., Chen, B., Liu, W., Alland, D., Sacchettini, J. C., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06365.x · Cited by 168
Rosenkrands, I., Weldingh, K., Jacobsen, S., Veggerby Hansen, C., Florio, W., Gianetri, I., & Andersen, P. (2000) · Electrophoresis · doi:10.1002/(sici)1522-2683(20000301)21:5<935::aid-elps935>3.0.co;2-p · Cited by 173
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
Shafer, R. W., & Edlin, B. R. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.683 · Cited by 174
EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets
Dover, L. G., Alahari, A., Gratraud, P., Gomes, J. M., Bhowruth, V., Reynolds, R. C., Besra, G. S., & Kremer, L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01063-06 · Cited by 168
Nair, J., Rouse, D. A., Bai, G., & Morris, S. L. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb00924.x · Cited by 163
Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
Wilson, T. M., de Lisle, G. W., & Collins, D. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02276.x · Cited by 166
Detection of Multidrug Resistance in Mycobacterium tuberculosis
Sekiguchi, J.-I., Miyoshi-Akiyama, T., Augustynowicz-Kopeć, E., Zwolska, Z., Kirikae, F., Toyota, E., Kobayashi, I., Morita, K., Kudo, K., Kato, S., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00750-06 · Cited by 166
Alland, D., Steyn, A. J., Weisbrod, T., Aldrich, K., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.7.1802-1811.2000 · Cited by 165
Ioerger, T. R., Koo, S., No, E.-G., Chen, X., Larsen, M. H., Jacobs, W. R., Pillay, M., Sturm, A. W., & Sacchettini, J. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007778 · Cited by 165
Johnsson, K., Froland, W. A., & Schultz, P. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2834 · Cited by 160
Zhang, S., Chen, J., Shi, W., Liu, W., Zhang, W., & Zhang, Y. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.38 · Cited by 160
Self-citationAlbumin-based nanoparticles: a promising strategy to overcome cancer drug resistance
Hassanin, I. A., & Elzoghby, A. O. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.68 · Cited by 200
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
Multiple thioredoxin-mediated routes to detoxify hydroperoxides in Mycobacterium tuberculosis
Jaeger, T., Budde, H., Flohé, L., Menge, U., Singh, M., Trujillo, M., & Radi, R. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.11.021 · Cited by 160
Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides
He, X., Alian, A., & de Montellano, P. R. O. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.013 · Cited by 158
Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis
Slayden, R. A., Lee, R. E., Armour, J. W., Cooper, A. M., Orme, I. M., Brennan, P. J., & Besra, G. S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2813 · Cited by 156
Marttila, H., Soini, H., Eerola, E., Vyshnevskaya, E. B., Vyshnevskiy, B. I., Otten, T. F., Vasilyef, A. V., & Viljanen, M. K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2443 · Cited by 186
Hu, D., Zhong, L., Wang, M., Li, H., Qu, Y., Liu, Q., Han, R., Yuan, L., Shi, K., Peng, J., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201806199 · Cited by 157
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Slayden, R. A., Lee, R. E., Jr., & Barry, C. E. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02145.x · Cited by 172
The Prodrug Activator EtaA from Mycobacterium tuberculosis Is a Baeyer-Villiger Monooxygenase
Fraaije, M. W., Kamerbeek, N. M., Heidekamp, A. J., Fortin, R., & Janssen, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307770200 · Cited by 152
Sreevatsan, S., Pan, X., Zhang, Y., Deretic, V. P., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.600 · Cited by 152
Self-citationAllelic exchange in Mycobacterium tuberculosis with long linear recombination substrates
Balasubramanian, V, Pavelka, M. S., Bardarov, S. S., Martin, J., Weisbrod, T. R., McAdam, R. A., Bloom, B. R., & Jacobs, W. R. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.273-279.1996 · Cited by 150
Niemann, S., Köser, C. U., Gagneux, S., Plinke, C., Homolka, S., Bignell, H., Carter, R. J., Cheetham, R. K., Cox, A., Gormley, N. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007407 · Cited by 150
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research
Sparks, I. L., Derbyshire, K. M., Jacobs, W. R., & Morita, Y. S. (2023) · Journal of Bacteriology · doi:10.1128/jb.00337-22 · Cited by 149
Ohno, H., Koga, H., KOHNO, S., Tashiro, T., & Hara, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.1053 · Cited by 149
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420
Blondiaux, N., Moune, M., Desroses, M., Frita, R., Flipo, M., Mathys, V., Soetaert, K., Kiass, M., Delorme, V., Djaout, K., et al. (2017) · Science · doi:10.1126/science.aag1006 · Cited by 148
Distribution of reactive oxygen species defense mechanisms across domain bacteria
Johnson, L. A., & Hug, L. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.03.032 · Cited by 161
Catalase-peroxidase KatG of Burkholderia pseudomallei at 1.7Å resolution
Carpena, X., Loprasert, S., Mongkolsuk, S., Switala, J., Loewen, P. C., & Fita, I. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00122-0 · Cited by 146
Heifets, L. B., & Cangelosi, G. A. (1999) · PubMed · Cited by 177
Rustad, T. R., Minch, K. J., Ma, S., Winkler, J. K., Hobbs, S., Hickey, M., Brabant, W., Turkarslan, S., Price, N. D., Baliga, N. S., et al. (2014) · Genome Biology · doi:10.1186/preaccept-1701638048134699 · Cited by 146
Hirano, K., Abe, C., & Takahashi, M. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.8.2663-2666.1999 · Cited by 149
Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG
Zahrt, T. C., Song, J., Siple, J., & Deretic, V. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02321.x · Cited by 138
Kiepiela, P., Bishop, K. S., Smith, A. N., Roux, L., & York, D. F. (2000) · Tubercle and Lung Disease · doi:10.1054/tuld.1999.0231 · Cited by 153
Pym, A. S., Domenech, P., Honoré, N., Song, J., Deretic, V., & Cole, S. T. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02427.x · Cited by 138
Self-citationMechanisms of Drug Resistance in Mycobacterium tuberculosis
Cole, S. T. (1994) · Immunobiology · doi:10.1016/s0171-2985(11)80466-3 · Cited by 140
Self-citationMutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis
Hirano, K., Takahashi, M., Kazumi, Y., Fukasawa, Y., & Abe, C. (1998) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(98)80004-x · Cited by 163
Transformation of mycobacterial species using hygromycin resistance as selectable marker
Garbe, T. R., Barathi, J., Barnini, S., Zhang, Y., Abou-Zeid, C., Tang, D., Mukherjee, R., & Young, D. B. (1994) · Microbiology · doi:10.1099/13500872-140-1-133 · Cited by 136
Self-citationWei, J., Dahl, J. L., Moulder, J. W., Roberts, E. A., Gaora, P. Ó., Young, D. B., & Friedman, R. L. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.2.377-384.2000 · Cited by 151
Self-citationSafi, H., Sayers, B., Hazbón, M. H., & Alland, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01486-07 · Cited by 149
Comparative study of catalase-peroxidases (KatGs)
Singh, R., Wiseman, B., Deemagarn, T., Jha, V., Switala, J., & Loewen, P. C. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.12.008 · Cited by 135
The pathways and outcomes of mycobacterial NHEJ depend on the structure of the broken DNA ends
Aniukwu, J., Glickman, M. S., & Shuman, S. (2008) · Genes & Development · doi:10.1101/gad.1631908 · Cited by 125
Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid
Argyrou, A., Vetting, M. W., Aladegbami, B. G., & Blanchard, J. S. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1089 · Cited by 131
Heym, B., Stavropoulos, E., Honoré, N., Domenech, P., Saint-Joanis, B., Wilson, T. M., Collins, D. M., Colston, M. J., & Cole, S. T. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1395-1401.1997 · Cited by 131
Self-citationThirty years of heme catalases structural biology
Díaz-Vilchis, A., Loewen, P. C., Fita, I., & Carpena, X. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.12.011 · Cited by 130
Drug resistance mechanisms and drug susceptibility testing for tuberculosis
Miotto, P., Zhang, Y., Cirillo, D. M., & Yam, W. C. (2018) · Respirology · doi:10.1111/resp.13393 · Cited by 130
Self-citationTorres, M. J., Criado, A., Palomares, J. C., & Aznar, J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3194-3199.2000 · Cited by 144
Interventions for tuberculosis control and elimination.
Rieder, H. L., & Disease, L. (2002) · Cited by 162
Martins, F. E. L., Santos, S., Ventura, C. M., Elvas‐Leitão, R., Santos, L., Vitorino, S., Reis, M. A. M., Miranda, V. P. B., Correia, H. F., Aires‐de‐Sousa, J., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.077 · Cited by 137
Nitazoxanide Kills Replicating and Nonreplicating Mycobacterium tuberculosis and Evades Resistance
de Carvalho, L. P. S., Lin, G., Jiang, X., & Nathan, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9010719 · Cited by 129
Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents
De, P., Yoya, G. K., Constant, P., Bedos‐Belval, F., Duran, H., Saffon‐Merceron, N., Daffé, M., & Baltas, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101510d · Cited by 128
Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis
Ahmad, S., & Mokaddas, E. M. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.07.010 · Cited by 128
Efflux Pump Gene Expression in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates
Li, G., Zhang, J., Guo, Q., Jiang, Y., Wei, J., Zhao, L., Zhao, X., Lu, J., & Wan, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119013 · Cited by 140
Phetsuksiri, B., Baulard, A. R., Cooper, A. M., Minnikin, D. E., Douglas, J. D., Besra, G. S., & Brennan, P. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1042 · Cited by 127
Saint‐Joanis, B., Souchon, H., Wilming, M., Johnsson, K., Alzari, P. M., & Cole, S. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380753 · Cited by 139
Self-citationPeroxiredoxins in Bacterial Antioxidant Defense
Dubbs, J. M., & Mongkolsuk, S. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-6051-9_7 · Cited by 130
North, E. J., Jackson, M., & Lee, R. E., Jr. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612819666131118203641 · Cited by 135
Biomimetic Chemical Catalysts in the Oxidative Activation of Drugs
Bernadou, J., & Meunier, B. (2004) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.200303191 · Cited by 121
Frénois, F., Engohang‐Ndong, J., Locht, C., Baulard, A. R., & Villeret, V. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.020 · Cited by 131
Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice
Ordway, D. J., Sonnenberg, M. G., Donahue, S. A., Belisle, J. T., & Orme, I. M. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.741-743.1995 · Cited by 120
Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid
Zhang, Y., Dhandayuthapani, S., & Deretic, V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13212 · Cited by 119
Self-citationDhandayuthapani, S., Zhang, Y., Mudd, M. H., & Deretic, V (1996) · Journal of Bacteriology · doi:10.1128/jb.178.12.3641-3649.1996 · Cited by 120
Self-citationMeier, A., Heifets, L. B., Wallace, R. J., Zhang, Y., Brown, B. A., Sander, P., & Böttger, E. C. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.2.354 · Cited by 121
Self-citationStrain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis
Borrell, S., & Gagneux, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03556.x · Cited by 140
Guo, H., Seet, Q., Denkin, S. M., Parsons, L. M., & Zhang, Y. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46718-0 · Cited by 149
Self-citationAltered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis
Karakousis, P. C., Williams, E. P., & Bishai, W. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm485 · Cited by 118
Haas, W., Schilke, K., Brand, J., Amthor, B., Weyer, K., Fourie, P. B., Bretzel, G., Sticht-Groh, V., & Bremer, H. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1601 · Cited by 115
The new diagnostic mycobacteriology laboratory
Salfinger, M., & Pfyffer, G. E. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02111498 · Cited by 129
Restriction Fragment Length Polymorphism Typing of Mycobacteria
van Soolingen, D., de Haas, P. E. W., & Kremer, K. (2003) · Humana Press eBooks · doi:10.1385/1-59259-147-7:165 · Cited by 114
Cockerill, F. R., Uhl, J. R., Temesgen, Z., Zhang, Y., Stockman, L., Roberts, G. D., Williams, D. L., & Kline, B. C. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.240 · Cited by 114
Self-citationKumar, D., Beena, Khare, G., Kidwai, S., Tyagi, A. K., Singh, R., & Rawat, D. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.005 · Cited by 113
Kurz, S. G., Furin, J. J., & Bark, C. M. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.010 · Cited by 126
Arnadottir, G. A., Norddahl, G. L., Guðmundsdóttir, S., Agustsdottir, A. B., Sigurðsson, S., Jensson, B. Ö., Bjarnadóttir, K., Theódórs, F., Benónísdóttir, S., Ivarsdottir, E. V., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06964-x · Cited by 116
Mycobacterial Cell Wall: A Source of Successful Targets for Old and New Drugs
Vilchèze, C. (2020) · Applied Sciences · doi:10.3390/app10072278 · Cited by 126
Metadata
- Authors
- Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S.
- Affiliations
- Hammersmith Hospital (GB)
- Institut Pasteur (FR)
- Venue
- Nature
- Published
- 1992-08-13
- Volume
- 358
- Issue
- 6387
- Pages
- 591-593
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2058925610
- Cited by
- 1,299
- References
- 17
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 28 · 2023: 26 · 2022: 35 · 2021: 34 · 2020: 47 · 2019: 45 · 2018: 49 · 2017: 50 · 2016: 36 · 2015: 47 · 2014: 69 · 2013: 37 · 2012: 50
- FWCI
- 37.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- isoniazid resistance, Mycobacterium tuberculosis, katG gene, catalase-peroxidase, multidrug resistance, Mycobacterium smegmatis, Escherichia coli, gene deletion, antitubercular agents, tuberculosis
- MeSH terms
- Amino Acid Sequence, Bacterial Proteins, Base Sequence, Catalase, Cloning, Molecular, DNA, Bacterial, Drug Resistance, Microbial, Escherichia coli, Genes, Bacterial, Isoniazid, Molecular Sequence Data, Mutation, Mycobacterium tuberculosis, Peroxidases, Plasmids, Blotting, Southern, Restriction Mapping, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.